Literature DB >> 10468350

Gonadotropin-releasing hormone-agonist as a neoadjuvant therapy for Sertoli-Leydig cell tumors of the ovary.

H T Chao1, P H Wang, H D Lin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468350     DOI: 10.1016/s0020-7292(99)00071-5

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  3 in total

1.  Postmenopausal hyperandrogenism of ovarian origin: A clinicopathologic study of five cases.

Authors:  S Ajith; George Beena; Nitu Mariam Mathew; E K Omana
Journal:  J Midlife Health       Date:  2016 Oct-Dec

Review 2.  Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism.

Authors:  Eng-Loon Tng; Jeanne May May Tan
Journal:  J Endocr Soc       Date:  2020-11-05

3.  Treatment of high risk Sertoli-Leydig cell tumors of the ovary using a gonadotropin releasing hormone (GnRH) analog.

Authors:  Harsha Prasada Lashkari; Ruth Nash; Assunta Albanese; Bruce Okoye; Robert Millar; Kathy Pritchard-Jones
Journal:  Pediatr Blood Cancer       Date:  2012-11-28       Impact factor: 3.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.